Major blockchain health data company Longenesis has signed an agreement with leading South Korean hospital Gil Medical Center to create a blockchain technology solution for managing health data.

According to a press release by Longenesis partner Insilico Medicine (Apr 23), Longenesis intends to establish a blockchain-based solution for Gil Medical Center built on Bitfury’s open-source Exonum blockchain framework. Longenesis is actually a partnership between Insilico Medicine, an artificial intelligence (AI) company that uses deep learning for drug discovery, and the Bitfury Group.

The solution is aimed to streamline data collection and aggregation, enhance medical research processes, and enable transparent patient consent management. As Gil Medical Center is also well known as a medical provider for foreigners in South Korea, the solution will also address specific compliance needs of patients, including being in line with the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA).

The Longenesis health data management solution will enable Gil Medical Center to transfer and manage patients’ data on its platform, and allow patients to access their data as well. Better management of consent forms and status will also boost the facilitation of clinical trials.

“Gil General Hospital has a splendid reputation for being on the edge of adopting latest innovation. We are honored to mark our Korean presence with a partnership like such,” said Garri Zmudze, CEO of Longenesis.

Earlier this month, The Crypto Sight reported that Bitfury and Longenesis introduced a new blockchain-based healthcare management system that addresses compliance with GDPR and HIPAA.

Last month, another Korean hospital said it is exploring the use of blockchain technology. Seoul Medical Center said it plans to launch a blockchain technology platform called “Smart Hospital Service” to improve the quality of medical services, ensure data accuracy, and reduce processing time, reported The Crypto Sight.